&#226;€‹Biopharmaceutical company.
Issues related to S. 3032 - the FDA STATES Act, and Health and Human Services pertaining to CBD policies. Appropriations issues related to the FDA enforcement of non-FDA approved CBD products; FY 2022 Agriculture, Food and Drug Administration Appropriations. Issues related to the FDA and S. 3032 - the FDA STATES Act, and Health and Human Services pertaining to CBD policies.
HCR - Health Issues BUD - Budget/Appropriations MED - Medical/Disease Research/Clinical Labs
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
TIBER CREEK GROUP
750 9th Street NW, Suite 501, Washington, DC, 20001, US
MATTHEW LEFFINGWELL JOHN MICHAEL GONZALEZ TIMOTHY A MOLINO EMILY KIRLIN MATTHEW LEFFINGWELL JOHN MICHAEL GONZALEZ TIMOTHY A MOLINO EMILY KIRLIN MATTHEW LEFFINGWELL JOHN MICHAEL GONZALEZ TIMOTHY A MOLINO EMILY KIRLIN